piperidine derivatives (Pierre Fabre)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepiperidine derivatives (Pierre Fabre)
Drug Alias Name2,4,6-trimethoxyphenylimidazolidinoneR-47273
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-1Adrenergic receptors alpha-2
Therapy Area/IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPierre Fabre Ltd
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A